Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. [electronic resource]
Producer: 19970725Description: 2606-10 p. digitalISSN:- 0008-5472
- Adaptor Proteins, Signal Transducing
- Adaptor Proteins, Vesicular Transport
- Calcium-Calmodulin-Dependent Protein Kinases -- metabolism
- Cell Division -- drug effects
- Female
- Humans
- Insulin Receptor Substrate Proteins
- Insulin-Like Growth Factor I -- pharmacology
- Mitogen-Activated Protein Kinase 1
- Phosphoproteins -- metabolism
- Phosphorylation -- drug effects
- Proteins -- metabolism
- Receptor, IGF Type 1 -- metabolism
- Shc Signaling Adaptor Proteins
- Signal Transduction -- physiology
- Src Homology 2 Domain-Containing, Transforming Protein 1
- Tamoxifen -- pharmacology
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.